期刊文献+

前列腺癌与良性前列腺增生细胞株差异核基质蛋白的鉴定 被引量:3

Nuclear matrix proteins differentially expressed in human prostate cancer cell lines and benign prostatic hyperplasia epithelial cell line
下载PDF
导出
摘要 目的:鉴定人前列腺癌雄激素依赖性细胞株LNCaP、前列腺癌雄激素非依赖性细胞株PC-3与良性前列腺增生细胞株BPH-1之间差异表达的核基质蛋白(nuclear matrix proteins,NMPs)。方法:常规制备各细胞株NMPs,应用双向凝胶电泳对其进行分离;对差异表达的蛋白质点行MALDI-TOF-MS/MS质谱分析,数据库搜索并鉴定。结果:成功获得了分辨率高、重复性好的不同细胞株NMPs双向凝胶电泳图谱;初步鉴定出包含酶、调节蛋白、RNA结合蛋白及各种因子在内的12个差异表达的蛋白质,在癌细胞株中3个NMPs表达上调,9个下调。结论:人前列腺癌细胞与良性前列腺增生细胞之间NMPs表达存在明显差异;初步筛选出12个差异NMPs,其表达水平及功能与疾病的联系需进一步研究。 Objective: To compare the expression of nuclear matrix proteins (NMPs) in benign prostatic hyperplasia ( BPH) epithelial cell line BPH-1 versus those in androgen-dependent human prostate cancer cell line LNCap and androgen-independent prostate cancer cell line PC-3. Methods : We isolated NMPs from the BPH-1, LNCap and PC-3 cell lines by 2-dimensional electrophoresis (2-DE), analyzed the differentially expressed proteins by matrix-assisted laser desorption / ionization time of flight mass sPectrometry (MALDI-TOF-MS), and identified them by peptide mass fingerprint and database searching. Results: We successfully obtained well-resolved reproducible 2-DE patterns of NMPs in human prostate cancer cell lines, identified 12 differentially expressed NMPs ineluding enzymes, regulatory proteins, RNA-binding protein and various other factors, 3 up-regulated and 9 down-regulated in prostate cancer cell lines. Conclusion: There are obvious differences in the expressions of NMPs between human prostate cancer cell lines and benign prostatic hyperplasia epithelial cell line.
出处 《中华男科学杂志》 CAS CSCD 2012年第7期583-589,共7页 National Journal of Andrology
基金 中央级公益科研院所基本科研业务费专项(2009GJSSJKB07)~~
关键词 前列腺癌雄激素依赖性LNCaP细胞株 前列腺癌雄激素非依赖性PC-3细胞株 良性前列腺增生 BPH-1细胞株 核基质蛋白 LNCap prostate cancer cell PC-3 prostate cancer cell benign prostatic hyperplasia epithelial cell nuclear matrix protein
  • 相关文献

参考文献18

二级参考文献41

共引文献196

同被引文献26

  • 1Yuan Wang,Jin-Jin Yu,Ting Zhu,Ling Xu,Ming Xu,Yu-Zheng Huang,Hong Pu,Chun-Qing Yu.Analysis of diferentially expressed protein from primary and recurrent ovarian cancer serum[J].Asian Pacific Journal of Tropical Medicine,2012,5(7):573-576. 被引量:5
  • 2张瑜,张怡,林秋华.孕激素对人子宫内膜癌细胞系Ishikawa影响的蛋白质组学研究[J].南方医科大学学报,2006,26(8):1110-1113. 被引量:6
  • 3Stamey T A, Caldwell M, McNeal J E, et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years [J]? J Urol, 2004, 172(4Pt1): 1297-1301. 被引量:1
  • 4Dhir R, Vietmeier B, Arlotti J, et aL Early identifica- tion of individuals with prostate cancer in negative biopsies [J]. J Urol, 2004, 171 (4).- 1419,1423;. 被引量:1
  • 5Alvarez A; Lokeshwar V B. Bladder cancer biomark- ers: current developments and future implementation [J]. Curr OpinUrol, 2007,17(5): 341-346. 被引量:1
  • 6Leman E S, Cannon G W, TrockB J, et al. EPCA-2: a highly specific serum marker for prostate cancer[J]. Urology, 20071 69(4): 714-720. 被引量:1
  • 7Thomason I M, Pauler D K, Goodmen P J, et al. Prevalence of prostate cancer among men with a pros- tare-specific antigen level<or = 4.0 ng/ml per millili- ter[J]. N Eng J Med, 2004, 350(22): 2239-2246. 被引量:1
  • 8Parekh N, Lin Y, Marcella S. et al. Associations of lifestyle and physiologic factors with prostate specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004) [J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(9) : 2467-2472. 被引量:1
  • 9齐淑贞,张国成,张津萍,曾学思,曹元华,钟铭英,陶小华,刘彤云,王千秋,杨荣阁.人乳头瘤病毒高低危基因型感染子宫颈组织的比较蛋白质组学分析及其差异[J].中国医学科学院学报,2007,29(5):597-602. 被引量:3
  • 10Yang F, Song L , Wang H, et al. Quercetin in prostate cancer: Chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (Review)[J]. Oncol Rep, 2015,33 (6) :2659-2668. 被引量:1

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部